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Abstract
Objective: To study pathophysiologic pathways in spontaneous preterm birth and possibly the
racial disparity associating with maternal and fetal genetic variations, using bioinformatics tools.
Methods: A large scale candidate gene association study was performed on 1442 SNPs in 130
genes in a case (preterm birth < 36 weeks) control study (term birth > 37 weeks). Both maternal
and fetal DNA from Caucasians (172 cases and 198 controls) and 279 African-Americans (82 cases
and 197 controls) were used. A single locus association (genotypic) analysis followed by
hierarchical clustering was performed, where clustering was based on p values for significant
associations within each race. Using Ingenuity Pathway Analysis (IPA) software, known
pathophysiologic pathways in both races were determined.
Results: From all SNPs entered into the analysis, the IPA mapped genes to specific disease functions.
Gene variants in Caucasians were implicated in disease functions shared with other known disorders;
specifically, dermatopathy,inflammation, andhematological disorders. Thismayreflectabnormalcervical
ripening and decidual hemorrhage. In African-Americans inflammatory pathways were the most
prevalent. In Caucasians, maternal gene variants showed the most prominent role in disease functions,
whereas in African Americans it was fetal variants. The IPA software was used to generate molecular
interaction maps that differed between races and also between maternal and fetal genetic variants.
Conclusion: Differences at the genetic level revealed distinct disease functions and operational
pathways in African Americans and Caucasians in spontaneous preterm birth. Differences in
maternal and fetal contributions in pregnancy outcome are also different between African
Americans and Caucasians. These results present a set of explicit testable hypotheses regarding
genetic associations with preterm birth in African Americans and Caucasians
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Preterm birth (< 37 weeks of gestation) rates vary
considerably between racial groups in the United States.
The rate is 18.4% in non-Hispanic African-Americans
and 11.7% in non-Hispanic Caucasians in 2005 [1]. The
African American population has a disproportionate
burden of several adverse socioeconomic and environ-
mental factors that have an indisputable connection with
PTB [2]. Nevertheless, racial differences in preterm birth
cannot be fully explained based on behavioral, psycho-
social, or socioeconomic factors [3-5]. Moreover, there
are numerous examples in the scientific literature in
which racial disparity in disease prevalence is closely
associated with genetic variation [6], and genes that
regulate immune and hematological functions are over-
represented among these, presumably reflecting adapta-
tion of ancestral populations to geographically-restricted
pathogens [7].
Understanding spontaneous preterm birth is difficult
due to etiologic and pathophysiologic heterogeneities
and racial disparity can further complicates this. Etiolo-
gic factors such as infection, stress, placental abruption,
uterine distension, and preterm premature rupture of
membranes, among others are associated with preterm
b i r t hi nb o t hr a c e s .R e d u n d a n c yo fb i o c h e m i c a lp a t h -
ways and biomarkers of preterm birth regardless of
etiology suggests pathophysiologic heterogeneity. One
explanation for racial disparity may be genetic variations
(polymorphisms) that differ in frequency between races
or that provide a different genetic context for particular
polymorphisms to function. A review of the literature
suggests emerging evidence for gene-gene interactions
(epistasis) and gene-environment interactions in preterm
birth [8-10], some of which may affect African Americans
and Caucasians differently [11]. Candidate gene studies
of preterm birth indicate greater than expected (60–80%
observed for PTB candidate genes vs. ~42% average
a c r o s st h eg e n o m ea l l e l ea n dg e n o t y p es i n g l en u c l e o t i d e
polymorphisms (SNPs) frequencies differences between
African-Americans and Caucasians [12,13]. In the con-
text of gene-gene and gene-environment interactions that
are becoming increasingly apparent, these differences
can affect the ability to detect both single SNP associa-
tions and critical pathways between populations, indi-
cating that genetic architectures in the two groups may
affect pregnancy outcome [14,15].
In addition to static genetic markers, dynamic biomarkers
in amniotic fluid and fetal membranes also reveal
significant racial disparity, such as inflammatory marker
expression and their concentrations in preterm birth
[16,17]. Studies suggest that biomarkers thought to be
indicators of preterm birth may not be generalizable.
Therefore, a simplified, uniform approach to risk identi-
fication and common intervention may not be adequate
because of different etiological factors that involve many
biomolecular factors. Furthermore, preterm birth can be a
function of both maternal and fetal risk factors and their
interactions at the genetic and biomarker level making the
clinical outcome exceedingly complex.
Based on the evidence generated in our laboratory on
genetic (both maternal and fetal) and biomarker data
from African-Americans and Caucasians [11-17], we
hypothesize that genetic predispositions in preterm
birth pathway genes differentially affect biomolecular
events in each race and this may explain some of the
racial disparity. To assess this, genotyping data generated
from a large scale candidate gene study were subjected to
pathway analyses, using bioinformatics tools [18,19].
Since genes operate within biological networks, we used
the Ingenuity Systems Pathways Analysis Software and
Knowledge Base (IPA) to estimate whether the pattern of
preterm birth candidate genes points to particular
biomolecular networks or disease mechanism(s) in
African Americans and Caucasians.
Methods
This study was approved by the institutional review
board at TriStar, the parent company institutional review
board of record for Centennial Women's Hospital,
Nashville, Tennessee (USA).
Genetic analysis performed on a case control study was
used for this report. Mothers between the ages of 18 and
40 were recruited. Gestational age was determined by
last menstrual period and corroborated by ultrasound
dating. Cases (spontaneous preterm birth) were defined
as presence of regular uterine contractions at < 36
0/7
weeks gestation (2 contractions/10 minutes with docu-
mented cervical changes) followed by delivery. Cases
and controls were selected from a Nashville cohort
between September 2003 and December 2006. Subjects
presented with preterm or term labor were given an
opportunity to consent for the study when they matched
ourinclusioncriteria.Subjectswithmedicallyindicatedpre-
term births such as multiple gestations, preeclampsia, pre-
termprematureruptureofthemembranes,placentalprevia,
infant anomalies, gestational diabetes, poly- and oligohy-
dramnios, and other complications such as surgeries during
pregnancies were excluded [11-17]. Controls consisted of
women having normal labor and delivery at term (≥ 37
0/7
weeks) with no medical or obstetrical complications during
pregnancy.
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that traces ethnicity back two generations from the
parents [11-17]. Individuals who had more than one
racial group in their ancestry were excluded from the
study [18-20]. African Americans and Caucasians of non-
Hispanic origin was included in this study.
High-throughput candidate gene association studies were
performed on 370 maternal (172 cases and 198 controls)
and 319 fetal (140 cases and 179 controls) DNA samples
from Caucasians and 279 maternal (82 cases and 197
controls) and 243 fetal (65 case and 183 control) samples
from African-Americans. The candidate genes are listed in
our earlier publications [16,17]. A total of 1536 tag SNPs
were screened in 130 preterm birth candidate genes.
Genotyping was performed by Illumina's GoldenGate
genotyping system [21]. We compared African American
cases to Caucasian cases, African-American controls to
Caucasian controls for both maternal and fetal DNA.
Statistical analysis
Statistical tests for differences between case and control
and African-American and Caucasian allele and geno-
type frequencies, measurements of allele frequencies and
tests deviations from Hardy Weinberg Equilibrium
(HWE) were calculated by the use of Powermarker
statistical software [22]. Statistical significance for all
single locus tests of association and tests for the
deviation from HWE were performed with Fishers
Exact tests. Clinical and demographic characteristics
between cases and controls were compared using
Shapiro-Wilks tests of normality on gravidity, gesta-
tional age, gestational weight, APGAR 1, and APGAR 5.
All measurements deviated significantly from normality;
as a result Mann-Whitney two-sample rank sum tests
were used to compare case and control groups. Standard
t-tests were used to test whether maternal age differed
between cases and controls. c
2 or Fisher's exact tests
were used to test for differences in the counts of smokers
and non-smokers, income differences, and insurance
differences between cases and controls. STATA 9.0
statistical software was used for all analyses of clinical
a n dd e m o g r a p h i cd a t aa n da nu n c o r r e c t e dpv a l u e≤
0.05 was considered significant.
Ingenuity systems pathway analysis (IPA) and
knowledgebase for pathway identification
To examine whether the SNPs found to be putatively-
associated with preterm birth in each race mapped to
different biological networks and disease functions, we
used IPA [23-26]. The gene variants that were statistically
significantly-associated with preterm birth (p ≤ 0.05) for
each race were entered into the IPA analysis tool. These
genes were termed "focus genes." The IPA software was
used to measure associations of these molecules with
other molecules and disease functions stored in its
knowledgebase. The knowledgebase encompasses rela-
tionships between proteins, genes, cells, tissues, xeno-
biotics, and diseases. The information is scientist-
curated, updated, and integrated from the published
literature and other databases such as OMIM, Gene
Ontology, and KEGG.
Disease function categories are among the biological
functional ontologies developed by experts across broad
domains of biology at IPA. There are 27 higher-order
disease and disorder categories in the IPA knowledge-
base, and below these higher order categories, there are
lower level and specific functions. The IPA functional
annotations have integrated GO data [27], but the IPA
knowledgebase is more extensive and complete, and
therefore uses a different but overlapping terminology.
Enrichment of focus genes in higher order disease
categories were evaluated by comparing p-values calcu-
lated by the IPA software. The p-value for a given
function is calculated by considering: 1) the number of
identified focus molecules from the user input that
participate in that disease and disorder function and,
2) the total number of molecules that are known to be
associated with that function in the IPA knowledge base.
To derive p-values, the IPA software uses a right-tailed
Fisher Exact Tests calculate likelihood that the associa-
tion between the set of focus genes and a disease
function is due to random chance. If a higher-order
disease and disorder category contains two or more
specific functions reaching statistical significance, the
software displays the most statistically significant value
on the y axis of the bar graph.
We used the IPA software to identify new molecular
network(s) that involve our focus genes. By drawing on
its knowledgebase, the IPA software models cellular and
molecular networks, including, binding, phosphoryla-
tion, proteolysis, nuclear receptor activation, gene
transcription, and sub-cellular localization. We mapped
focus genes to networks based on their mechanistic
associations with each other and partner molecules. The
IPA statistical algorithm identifies molecular pathways,
involving these focus genes based on their selective
interconnectivity with each other and additional mole-
cules stored in the genome-scale knowledgebase. These
networks are illustrated and ranked by the software for
significance of focus gene enrichment.
Results
Demographic and clinical data and single locus associa-
tions with preterm birth pertaining to this data set has
already been published [13,14]. Briefly, as per our
Reproductive Biology and Endocrinology 2009, 7:62 http://www.rbej.com/content/7/1/62
Page 3 of 16
(page number not for citation purposes)definition cases had shorter gestational age. Cases also
had lower birth weight and APGAR scores compared to
controls, irrespective of race. Frequency of clinical
parameters associated with preterm birth such as
histologic chorioamnionitis, intraamniotic infection,
bacterial vaginosis, and clinical chorioamnionitis (CRP
concentration, high fever, abdominal tenderness and
foul smelling vaginal discharge) also showed no
significant differences between the two races. In the
current manuscript we distinguish unique pathways
entailing maternal and fetal genetic variants associated
with preterm birth.
Because the patterns of genetic association and therefore
the detectable network patterns can be affected by
differences in genotype and allele frequencies, it is
important to assess the differences between our African-
Americans and Caucasians prior to IPA analysis. After
removing monomorphic markers and those with low
genotyping efficiency from 1536 SNPs, 1442 remained for
this analysis. Overall, the results indicate that the vast
majority of SNPs assayed differed between African-
Americans and Caucasians in genotype frequencies
(~68–80%), and that controls appeared to be slightly
more different than cases (Table 1). Of note, the vast
majority of differences observed were highly significant.
The proportion of comparisons with genotype frequency
differences more significant than p = 0.001, range from
935 of 1442 SNPs in maternal controls to 668 of 1442
SNPs in fetal cases. These data demonstrate that the
African-Americans and Caucasians were highly different in
terms of the distribution of genetic variation at the
candidate loci we studied. In addition, these proportions
exceed the average across genome differences expected
between Africans and Caucasians in the Hap Map data
(average ~55% [data not shown]).
Based on the IPA curated disease ontology we deter-
mined which disease functions were most significantly
associated with the aggregate of focus genes in each race.
From all SNPs entered into the analysis, the IPA mapped
129 genes. Thus, disease function analysis defined a
different set of genes for each group meeting the p ≤ 0.05
cutoff; specifically, 36 genes for Caucasian mothers,
39 genes for African American mothers, 35 genes for
Caucasian fetuses, and 39 genes for African-American
fetuses. These results indicate that the gene variants
entered into our IPA analyses have been identified in
the literature with a variety of diseases and disorders.
Figure 1 shows the top three disease functions for each
race as ranked by statistical significance that was
calculated by the IPA functional analysis algorithm.
Note that genes associated with inflammatory diseases
are significant in both races, but that the p-values suggest
greater significance in inflammation-associated genes in
African-Americans than in Caucasians. Additionally, in
the African Americans the fetal results are more
significant than the maternal, but this is not the case in
Caucasians. In general, the fetal results were more
significant in African Americans than the maternal
contribution for 13 higher order disease categories, but
only 4 such categories in Caucasians.
Within the IPA disease ontology tree, the disease-related
function contributing most to the significance was also
of interest. For example, under hematological diseases,
processes related to apoptosis and cell death were more
significant in African-American mothers (p = 5.56E-12 to
8.11E-11) than in Caucasian mothers (1.07E-7 to 1.90
E-4). Conversely, hematological "disorders", thrombosis,
and hemorrhage (also subsumed under hematological
"diseases") were significant in Caucasian mothers
(p-values 1.09E-6 to 1.73E-4) but did not reach
significance in African American mothers.
While these analyses revealed disease functions assigned
to our input genes, we were also interested in the
functional biological networks employing these genes
and proteins. (Figures 2, 3, 4, 5, 6, 7, 8, 9) Using the IPA
network algorithm, we constructed a series of connectiv-
ity maps derived from millions of molecular interactions
and regulatory processes housed in the IPA knowledge-
base (Figures 2 through 8). These networks were
generated based on their composite score, which
represents the negative log of the p-value for the
likelihood these molecules would be found together by
chance. Accordingly, a higher score indicates greater
statistical significance that molecules depicted in the
network are interconnected. Each network is a graphical
representation of the molecular relationships between
genes/gene products. Genes or gene products are
represented as nodes, and the biological relationship
Table 1: Differences between genotypic frequencies between
African Americans and Caucasians
Maternal DNA Cases Controls
% Genotype frequency
difference
68.5% (987/1440) 77.6% (1119/1442)
Fetal DNA
% Genotype frequency
difference
68.2% (984/1442) 80.2% (1156/1442)
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edges are supported by at least 1 reference from the
literature, from a textbook, or from canonical informa-
tion stored in the Ingenuity Pathways Knowledge Base.
For Caucasian mothers, IPA generated three highly
significant networks (scores 16 to 34), and Caucasian
fetuses had a different set of three networks (scores 13 to
38). For African-American mothers there were four
highly significant networks (scores 15 to 33), and
African-American fetuses had another four networks
(scores 13 to 40). Note each network includes a number
of "partner" molecules that were assigned to the network
by the IPA algorithm, but which were not among the
input genes.
Figure 1
Top disease and disorder functions determined by IPA to be overrepresented by focus genes. Panel A, Caucasian
mothers and their fetuses; panel B, African American mothers and their fetuses. Dark blue bars, maternal; light blue, fetal. The
p-value for a given diseases and disorder annotation is calculated by the IPA software using Fishers Exact Test taking into
account the number of focus genes that participate in that process in relation the total number of genes associated with
that process in the IPA knowledgebase.
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Biological pathways leading to preterm birth are inter-
twined and redundant, and can involve inflammation,
collagen remodeling, decidual vascular insufficiency,
and myometrial contraction. Thus, parturition represents
a tuned orchestration of regulatory loops. Therefore, in
this study we examined the hypothesis that genetic
variations in the molecules involved in these regulatory
networks are important determinants of preterm birth.
Our finding that preterm birth susceptibility genes
Figure 2
Top ranking gene/protein networks determined by IPA analysis in Caucasian maternal (net work score 34) and
fetal (net work score 38). Panel A, maternal networks; panel B, fetal networks. Solid lines show direct interaction
(binding/physical contact); dashed line, indirect interaction supported by the literature but possibly involving one or more
intermediate molecules that havenotbeen investigated definitively. Molecular interactionsinvolving only bindingare connectedwith
a solid line (noarrowhead) since directionality cannot beinferred. Focusgenes: pinkcolor, met criteria for case-control comparison
for genotype at p ≤ 0.05; red, met criteria for case-control comparison for genotype at p ≤ 0.001; grey, indicating one or more SNP
was analyzed in our data set but case-control comparison did not meet p ≤ 0.05; no color – additional interconnected genes
generated algorithmically by IPA, i.e., proteins, or complexes, including new potential biomarkers. *indicates that there was more
than one SNP probe for this gene tested and the most significant was placed into the analysis.
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inflammatory diseases, dermatologic and connective
tissue disorders (i.e. collagen metabolism disorders),
hematological disease (such as decidual hemorrhage),
and skeletal and muscular disorders (i.e. involving
inflammation, collagen, and muscle function) supports
the role of multiple physiological processes in preterm
birth (Table 2, 3, 4). Importantly, the relative relation-
ships/roles of these processes differed by race. Specifi-
cally, different mechanistic pathways appeared to be
Figure 3
Second ranking gene/protein networks determined by IPA analysis in Caucasian maternal (net work score 32)
and fetal (net work score 29). Panel A, maternal networks; panel B, fetal networks. Solid lines show direct interaction
(binding/physical contact); dashed line, indirect interaction supported by the literature but possibly involving one or more
intermediate molecules that have not been investigated definitively. Molecular interactions involving only binding are connected
with a solid line (no arrowhead) since directionality cannot be inferred. Focus genes: pink color, met criteria for case-control
comparison for genotype at p ≤ 0.05; red, met criteria for case-control comparison for genotype at p ≤ 0.001; grey, indicating
one or more SNP was analyzed in our data set but case-control comparison did not meet p ≤ 0.05; no color – additional
interconnected genes generated algorithmically by IPA, i.e., proteins, or complexes, including new potential biomarkers.
*indicates that there was more than one SNP probe for this gene tested and the most significant was placed into the analysis.
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in African Americans and Caucasians, as suggested by the
differences in the IPA scores for disease functions
between the two races (Table 2, 3). Among African-
Americans the prominent disease functions detected
involved inflammation, connective tissue disorders and
skeletal and muscle disorders, whereas in Caucasians
dermatological diseases and conditions (involving col-
lagen metabolism), inflammatory diseases, and hema-
tological diseases were most prominent. Tables 2, 3 and
Figure 4
Third ranking Gene/protein networks determined by IPA analysis in Caucasian maternal (net work score 16)
and fetal (net work score 13). Panel A, maternal networks; panel B, fetal networks. Solid lines show direct interaction
(binding/physical contact); dashed line, indirect interaction supported by the literature but possibly involving one or more
intermediate molecules that have not been investigated definitively. Molecular interactions involving only binding are
connected with a solid line (no arrowhead) since directionality cannot be inferred. Focus genes: pink color, met criteria for
case-control comparison for genotype at p ≤ 0.05; red, met criteria for case-control comparison for genotype at p ≤ 0.001;
grey, indicating one or more SNP was analyzed in our data set but case-control comparison did not meet p ≤ 0.05; no color –
additional interconnected genes generated algorithmically by IPA, i.e., proteins, or complexes, including new potential
biomarkers. *indicates that there was more than one SNP probe for this gene tested and the most significant was placed
into the analysis.
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disease and disorder functions in our IPA analysis, and
provides the context of these results with respect to
preterm birth. Further, while there was evidence for
maternal and fetal genetic contribution to preterm birth
risk in both races, the relative roles of maternal and fetal
variants to the disease functions was different in the two
races. In African-Americans the fetal genetic variants were
more prevalent, but in Caucasians the maternal disease
functions showed more significance. We conclude that
Figure 5
Top ranking gene/protein networks determined by IPA analysis in African Americans maternal (net work score 33)
and fetal (net work score 40). Panel A, maternal networks; panel B, fetal networks. Solid lines show direct interaction (binding/
physical contact); dashed line, indirect interaction supported by the literature but possibly involving one or more intermediate
molecules that have not been investigated definitively. Molecular interactions involving only binding are connected with a solid line
(no arrowhead) since directionality cannot be inferred. Focus genes: pink color, met criteria for case-control comparison for
genotype at p ≤ 0.05; red, met criteria for case-control comparison for genotype at p ≤ 0.001; grey, indicating one or more SNP was
analyzed in our data set but case-control comparison did not meet p ≤ 0.05; no color – additional interconnected genes generated
algorithmically by IPA, i.e., proteins, or complexes, including new potential biomarkers. *indicates that there was more than
one SNP probe for this gene tested and the most significant was placed into the analysis.
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labor process) and an individual's own genetic constitu-
tion the underlying cellular and molecular pathways that
lead to preterm birth may be more or less commonly
depending on race.
In this study molecular groupings generated by IPA
suggest a new way of examining SNP data to predict
events involved in preterm birth. The networks that were
found to be most significant (statistically) by IPA can be
viewed as modules of interacting molecules that act in
key physiological compartments involved in the patho-
physiology of preterm birth. For each network, the IPA
analysis generated new potential interacting biomarkers
(partner molecules) that are highly interconnected with
t h ev a r i a n tg e n e sw et e s t e da n dp r o v i d eas e to fn e w
Figure 6
Second ranking gene/protein networks determined by IPA analysis in African Americans maternal (net work
score 25) and fetal (net work score 15). Panel A, maternal networks; panel B, fetal networks. Solid lines show direct
interaction (binding/physical contact); dashed line, indirect interaction supported by the literature but possibly involving one or
more intermediate molecules that have not been investigated definitively. Molecular interactions involving only binding are
connected with a solid line (no arrowhead) since directionality cannot be inferred. Focus genes: pink color, met criteria for case-
control comparison for genotype at p ≤ 0.05; red, met criteria for case-control comparison for genotype at p ≤ 0.001; grey,
indicating one or more SNP was analyzed in our data set but case-control comparison did not meet p ≤ 0.05; no color – additional
interconnected genes generated algorithmically by IPA, i.e., proteins, or complexes, including new potential biomarkers. *indicates
that there was more than one SNP probe for this gene tested and the most significant was placed into the analysis.
Reproductive Biology and Endocrinology 2009, 7:62 http://www.rbej.com/content/7/1/62
Page 10 of 16
(page number not for citation purposes)testable hypotheses regarding predisposition to preterm
birth.
Based on candidate gene studies, our group has already
reported clear disparity in genetic associations with
preterm birth in both maternal and fetal genome
between African-Americans and Caucasians [10,13,14].
However, such studies provide little information on
biological relevance other than the most simplistic
relationships between single genes and PTB. The present
Figure 7
Third ranking Gene/protein networks determined by IPA analysis in Caucasian maternal (net work score 18) and
fetal (net work score 13). Panel A, maternal networks; panel B, fetal networks. Solid lines show direct interaction (binding/
physical contact); dashed line, indirect interaction supported by the literature but possibly involving one or more intermediate
molecules that have not been investigated definitively. Molecular interactions involving only binding are connected with a solid line
(no arrowhead) since directionality cannot be inferred. Focus genes: pink color, met criteria for case-control comparison for
genotype at p ≤ 0.05; red, met criteria for case-control comparison for genotype at p ≤ 0.001; grey, indicating one or more SNP
was analyzed in our data set but case-control comparison did not meet p ≤ 0.05; no color – additional interconnected genes
generated algorithmically by IPA, i.e., proteins, or complexes, including new potential biomarkers. *indicates that there was
more than one SNP probe for this gene tested and the most significant was placed into the analysis.
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risk factors that can ultimately predict risk based on
gene-gene and gene-environment interactions based on
documented biological pathways. The IPA approach
provides more insight into potential functional roles of
genes and more testable and biologically plausible
hypotheses. Therefore, Based we can now argue with
increased confidence that genetic variants linked with
preterm birth participate in discrete pathways that define
specific disease functions in each race.
Figure 8
Fourth ranking Gene/protein networks determined by IPA analysis in Caucasian maternal (net work score 15)
and fetal (net work score 13). Panel A, maternal networks; panel B, fetal networks. Solid lines show direct interaction
(binding/physical contact); dashed line, indirect interaction supported by the literature but possibly involving one or more
intermediate molecules that have not been investigated definitively. Molecular interactions involving only binding are
connected with a solid line (no arrowhead) since directionality cannot be inferred. Focus genes: pink color, met criteria for
case-control comparison for genotype at p ≤ 0.05; red, met criteria for case-control comparison for genotype at p ≤ 0.001;
grey, indicating one or more SNP was analyzed in our data set but case-control comparison did not meet p ≤ 0.05; no color –
additional interconnected genes generated algorithmically by IPA, i.e., proteins, or complexes, including new potential
biomarkers. *indicates that there was more than one SNP probe for this gene tested and the most significant was placed
into the analysis.
Reproductive Biology and Endocrinology 2009, 7:62 http://www.rbej.com/content/7/1/62
Page 12 of 16
(page number not for citation purposes)This systems biology approach enables the identification
of new pathways and genes. Understanding these disease
functions and molecular networking can help categorize
women into specific risk groups for targeted interven-
t i o n .T h i sa p p r o a c hi n t r o d u c e sf e wa s s u m p t i o n sc o n -
cerning the types of pathophysiological processes that
might be discerned. Accordingly, some "disease func-
tions" identified by IPA as being associated with preterm
birth may not have an obvious connection with
parturition or preterm birth. However, the strength of
Ingenuity is its broad and unbiased coverage of peer
reviewed literature in cell biology, organ physiology, and
pathology. Thus, the literature in diverse fields may be
used to reveal clues to preterm birth, and the disease
functions, it can provide substantial insight as long as
caution is used in interpreting the disease functions
output from IPA. We also emphasize that the primary
data on which these analyses are based is small and will
also require follow-up studies.
As with all studies connecting genetics, race, and PTB,
our findings could be misused as an excuse for failing to
rectify inequalities in social conditions and healthcare
delivery that have well established links with PTB.
However, genes act within environmental context, and
we do not suggest race can be used as a proxy for genetic
markers. For example, genes controlling inflammatory
pathways are related to susceptibility to bacterial
vaginosis, autoimmune disorders [7], and depression
[28]. If our data indicates that some mothers have
vulnerabilities in these pathways, this implies a need for
greater emphasis on preventive measures to improve the
socio-environmental conditions that bring about these
conditions.
In conclusion, we performed a network analysis to
identify molecules and risk pathways that were not
explicitly tested in our original genetic studies. These
analyses produced statistical and visual evidence of racial
disparity in key networks associated with other disease
phenotypes that can provide important insights into the
pathophysiology of preterm birth.
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(page number not for citation purposes)Table 2: Disease functions as detected by IPA based on significant genetic variations in maternal and fetal candidate genes in
Caucasians and its interpretation in spontaneous preterm birth
Disease functions as
detected by IPA
Genes involved in determining the disease functions Potential pathophysiological
role in preterm birth
Mother Fetus
Dermatologic disease
and conditions
COL1A1, COL3A1, COL5A1, COL5A2,
CTLA4, CYP19A1, IL5, IL10, IL18,
MMP3, MMP1, NFKBIA, PLAT, PTGS1,
TLR2, TLR7, TNFR1, TNFR2,
COL1A2, COL3A1, COL5A2,
CYP19A1, IGF1, IL5, IL1A, IL1B, IL1RN,
IL4R, MMP, NFKBIA, PGR, PTGS2, TLR7
Because dermatological disorders
typically involve combined collagen
remodeling aided by inflammation
and, this function appears to reflect
premature cervical ripening and
membrane weakening related to
preterm birth. Collagenolysis may
involve an underlying inflammatory
process as suggested by cytokines,
cytokine receptors, cytokine
signaling pathway genes that is likely
a secondary event.
Etiology Æ Collagenolysis Æ
inflammation Æ Premature cervical
ripening and membrane weakening
Æ Preterm birth.
Inflammatory disease CCL2, CTLA4, CYP19A1, F7, IL5, IL10,
IL18, IL1R1, MMP3, MMP1, NFKBIA,
PLA2G4A, PLAT,
PTGER3, PTGS1, TIMP3, TLR2, TNFR1,
TNFR2
CRHR2, CYP19A1, IGF1, IL5, IL10RA,
IL1A, IL1B, IL1RN, IL2RB, IL4R, KL,
MMP8, MMP1, NFKBIA, PGR, PTGS2,
TIMP3, TREM1
Underlying inflammatory
conditions associated with preterm
birth (see above)
Hematological disease CCL2, CTLA4, CYP19A1, F5, F7,
HSD11B1, IL5, IL10, IL18, IL1RAP,
NFKBIA, PLA2G4A, PLAT, PTGS1,
TLR2, TNFR1, TNFR2
CBS, IGF1, IL5, IL1A, IL1B, IL1RAP,
IL1RN, IL2RB, IL4R, MMP8, NFKBIA,
N F K B I E ,P G R ,P T G S 2
Involvement of genes in the
hematological pathway indicates
decidual hemorrhage and
associated problems associated
with Caucasian preterm birth.
Table 3: Disease functions as detected by IPA based on significant genetic variations in maternal and fetal candidate genes in African
Americans and its interpretation in spontaneous preterm birth
Disease functions
as detected by IPA
Genes involved in determining the
disease functions
Potential pathophysiological role in
preterm birth
Mother Fetus
Inflammatory
disease
ACE, CCL2, CTLA4, IFNG, IL4, IL15,
IL10RA, IL1B, IL1R1, IL2RA, IL2RB,
IL4R, IL6R, KL, MMP2, MMP8,
N F K B 1 ,N O D 2 ,N R 3 C 1 ,P O M C ,
PTGER3, SLC6A4, TIMP3, TNFR1,
TNFR2, VEGFA
CD14, CTLA4, IFNG, IL2, IL6, IL8,
IL10, IL15, IL10RB, IL1R1, IL1RN,
IL2RB, MMP2, MMP3, MMP8, MMP9,
NFKB1, NFKBIB, NOD2, PTGER3,
TIMP3, TLR4, TNF, TNFR1, TNFR2,
TREM1
Overwhelming inflammation appears to be the
primary effecter of preterm birth in African
Americans regardless of etiology. Fetal
response is dominant (see Figure 2) along with
complementary maternal contributions. This
combined inflammatory process that can
activate multitudes of other pathways seem
primary disease function resulting in preterm
birth
Etiology Æ Inflammation Æ Activation of
multitudes of uterotonic events Æ Preterm
birth
Connective tissue
disease
C C L 2 ,I F N G ,I L 4 ,I L 1 5 ,I L 1 0 R A ,I L 1 B ,
IL1R1, IL2RB, IL4R, IL6R, MMP2,
NFKB1, NR3C1, POMC, SLC6A4,
TIMP3, TNFR1, NFR2,
IFNG, IL6, IL8, IL10, IL15, IL1R1,
IL1RN, IL2RB, MMP2, MMP3, MMP9,
NFKB1, TIMP3, TLR4, TNF, TNFR1,
TNFR2
This function also involves immune and
inflammatory response genes. Matrix
metalloproteinases can function in
inflammation as well as collagen turnover
f u n c t i o n ;e . g .i n v o l v e di nc e r v i c a lr i p e n i n ga n d
membrane matrix degradation.
Skeletal and
muscular disorder
CCL2, CTLA4, IFNG, IL4, IL15,
IL10RA, IL1B, IL1R1, IL2RB, IL4R,
IL6R, KL, MMP2, NFKB1, NOD2,
NR3C1, POMC, SLC6A4, TNFR1,
TNFR2, VEGFA
CD14, CTLA4, IFNG, IL2, IL6, IL8,
IL10, IL15, IL1R1, IL1RN, IL2RB,
MMP2, MMP3, MMP9, NFKB1,
NFKBIB, NOD2, TLR4, TNF,
TNFR1, TNFR2, TSHR
Most of these genes function in inflammatory
regulation are related to rheumatic disorders,
including matrix metalloproteinases that are
also involved in cervical ripening and
membrane matrix degradation.
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